Biomeditsina va amaliyot jurnali, 2022 №3

Maqola mavzusi

FEATURES OF CHANGES IN THE MICROFLORA OF THE VAGINA TO WOMEN (64-70)

Mualliflar

YULDASHEVA Farangiz Ismatiloevna SAMIYEVA Gulnoza Utkurovna

Muassasa

SamDTU

Annotatsiya

Our body is inhabited by a large number of microorganisms. They live on the skin, in the mucous membranes of the mouth and nose, in the intestines, and in women and in the vagina. The vagina is covered with a multi-layered non-corneating squamous epithelium, which does not contain glands. [1,2,3,7,8]. The processes of physiological maturation of the cells of the vaginal mucosa, their peeling and the thickness of the surface layer are subject to cyclic changes in response to the action of sex hormones. [5,6]. The epithelium of the vagina, performing a protective function, ensures its resistance to the effects of pathogenic agents (bacteria, viruses, fungi). An important indicator of the resistance of the vaginal epithelium is the amount of glycogen, which is contained mainly in surface cells. Since these cells are constantly being exfoliated and destroyed, glycogen is released, providing a nutrient substrate for normal microflora. The amount of glycogen in the cells of the vaginal epithelium varies in the same woman throughout her life, as well as depending on the phase of the menstrual cycle. The maximum accumulation of glycogen occurs at the time of ovulation. [2, 7]. The vaginal microflora is strictly individual and may even be subject to changes in different phases of the menstrual cycle in a normal state. In addition, the concept of norm can be different for different age groups, ethnic groups and even geographical zones. In this regard, variants of normal microbiocenosis (normocenosis) of the vagina are possible [8,10].

Kalit so'zlar

Microflora, Colonization of a microorganism, normocinosis, biocinosis, menapause, lactobacilli, pathogen microorganism, peptostreptococci, bacteroids, staphylococci, streptococci, gardnerella, candida

Adabiyotlar

1. Analysis of the course of pregnancy in women infected with Ur.urealyticum, depending on the degree of colonization of the genital tract T.A. Melnikova, M.M. Padrul, E.S. Horowitz, G.I. Rabotnikova Perm Medical Journal. - 2017.- Vol. 34, No.2. - pp. 26-30. 2. Karapetyan, T.E. Aerobic vaginitis and pregnancy T. E.Karapetyan, V. V.Muravyeva, A. S.Ankirskaya Obstetrics and gynecology. - 2013.- No. 4.- pp. 25-28. 3. Kostin, I.N. Significance and results of the international research project "Human Microbiome" I.N.Kostin,L.Yu.Kuvankina, H.Yu. Simonovskaya StatusPraesens. – 2013. – №5(16). – P.9- 15 4. Kuzmin, V.N.The place and role of mycoplasma infection in the structure of inflammatory diseases of the pelvic organs V.N. 5. Kuzmin Gynecology. - 2015.- No. 2.- pp. 21-26 Laboratory diagnostics of bacterial vaginosis:methodological recommendations A.M. Savicheva, M.A. Bashmakova, T.V. Krasnoselskikh [et al.]. - St. Petersburg: Publishing House N-L, 2011.-28 p. 6. Tavo, V. Prevalence of Mycoplasma hominis and Ureaplasma urealyticum among women of reproductive age in Albania V. Tavo Med. Arch. - 2013. - Vol. 67, No. 1. - pp. 25-26. doi:10.5455/medarch.2013.67.25-26 7. Temporal and spatial changes in the human microbiota during pregnancy / D.B. DiGiulio, B.J. Callahan, P.J. Mcmurdy [et al.] PNAS.-2015. - vol. 112, No. 35. - pp.11060-11065. doi:10.1073 pnas.150287511 8. The composition and stability of the vaginal microbiota of normal pregnant women differ from the composition and stability of non-pregnant women R. Romero, S.S. Hassan, P. Hajer [et al.] Microbiome. - 2014. - Vol.2, No. 1. - p.4. doi:10.1186/2049-2618-2 9. Interaction between the microbiota of the vagina, the length of the cervix and treatment with vaginal progesterone to reduce the risk of premature birth L.M. Kindinger, P.R.Bennett, Y.S. Lee [et al.] Microbiome. - 2017. - Vol. 5, 1. - p.6.doi:10.1186 40168-016-0223 10. The role of infection in miscarriage S. Giakoumelou, N. Wheelhouse, K. Cuschieri [et al.] Hum. Reprod. Update. – 2016. – Vol. 22, № 1. – P.116-133. doi:10.1093/humupd/dmv041 11. The vaginal microbiome and preterm birth J.M. Fettweis, M.G.Serrano, J.P. Brooks [et al.] Nat. Med. - 2019. - Vol. 25, No. 6. - P.1012-1021. doi:10.1038/s41591-019-0450 12. Aldunate, M., Srbinowski, D., Herps, A.S., Latham, K.F., Ramsland, P.A., Gugasyan, R. and Tachejian, G... "Antimicrobial and immunomodulatory effects of lactic acid and short-chain fatty acids produced by the vaginal microbiota are associated with eubiosis and bacterial vaginosis" Frontiers of Physiology 6 issue, (2015 d). p.164. 13. Balkus J. E. i , , Richardson B.A., Rabe L.K., Taha T.E., Mgodi N., Casaro M.P.. "Bacterial vaginosis and the risk of infection with Trichomonas vaginalis in HIV-1-negative women". Sexually transmitted diseases. Vol. 41. No. 2. (2014). p. 123. 14. Bjartling S., Osser S., Persson K. "The relationship between Mycoplasma genitalium and pelvic inflammatory diseases after termination of pregnancy." International Journal of Obstetrics and Gynecology. Vol. 117. No. 3. (2010). pp. 361-364. 15. Borgdorf H. and Armstrong S. D., Xia D., Ndayisaba G. F. "Dysbiosis of the cervicovaginal microbiome is associated with proteome changes associated with changes in the cervicovaginal mucosal barrier". Immunology of the mucous membrane. Vol. 9. No. 3. (2016). pp. 621-633. 16. Bradford L.L., Ravel J. "Vaginal mycobioma: a modern view of fungi in women's health and diseases" Virulence. Vol. 8. No. 3. (2017). pp. 342-351. 17. Brotman R.M. "Bacterial vaginosis assessed by Gram staining and reduced colonization resistance to accidental gonococcal, chlamydial and trichomonas genital infections". Journal of Infectious Diseases. Vol. 202. No. 12. (2010). pp. 1907-1915